These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30234148)

  • 1. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients.
    Jordan SC; Bunnapradist S; Bromberg JS; Langone AJ; Hiller D; Yee JP; Sninsky JJ; Woodward RN; Matas AJ
    Transplant Direct; 2018 Sep; 4(9):e379. PubMed ID: 30234148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free DNA and Active Rejection in Kidney Allografts.
    Bloom RD; Bromberg JS; Poggio ED; Bunnapradist S; Langone AJ; Sood P; Matas AJ; Mehta S; Mannon RB; Sharfuddin A; Fischbach B; Narayanan M; Jordan SC; Cohen D; Weir MR; Hiller D; Prasad P; Woodward RN; Grskovic M; Sninsky JJ; Yee JP; Brennan DC;
    J Am Soc Nephrol; 2017 Jul; 28(7):2221-2232. PubMed ID: 28280140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Billings P; Lawrence C; Lowe D; Hidalgo LG;
    Transplantation; 2023 Mar; 107(3):709-719. PubMed ID: 36190186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status.
    Thongprayoon C; Vaitla P; Craici IM; Leeaphorn N; Hansrivijit P; Salim SA; Bathini T; Rivera FHC; Cheungpasitporn W
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32423115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived cell-free DNA: An independent biomarker in kidney transplant patients with antibody-mediated rejection.
    Cheng D; Liu F; Xie K; Zeng C; Li X; Ni X; Ge J; Shu L; Zhou Y; Shi H; Liu H; Chen J
    Transpl Immunol; 2021 Dec; 69():101404. PubMed ID: 33971294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation.
    Butiu M; Obrisca B; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Transplant Direct; 2022 Feb; 8(2):e1285. PubMed ID: 35187211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective.
    Rizvi A; Faiz S; Thakkar PH; Hussain S; Gamilla-Crudo AN; Kueht M; Mujtaba MA
    J Pers Med; 2023 Jul; 13(8):. PubMed ID: 37623456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population.
    Kumar N; Tandon A; Rana R; Rana DS; Bhalla AK; Gupta A; Sachdeva MP; Huirem RS; Chauhan K; Yashavarddhan MH; Basnal A; Gupta R; Mallick PK; Ganguly NK
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
    Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC
    Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant.
    Bromberg JS; Bunnapradist S; Samaniego-Picota M; Anand S; Stites E; Gauthier P; Demko Z; Prewett A; Armer-Cabral M; Marshall K; Kaur N; Bloom MS; Tabriziani H; Bhorade S; Cooper M; ;
    Transplantation; 2024 Apr; ():. PubMed ID: 38595232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function.
    Huang E; Haas M; Gillespie M; Sethi S; Peng A; Najjar R; Vo A; Jordan SC
    Transplantation; 2023 Jan; 107(1):274-282. PubMed ID: 35913057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
    Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
    Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.